New Anti-Tumor Hydrogel May Help In Fight Against Cancer, Ch...| MENAFN.COM

Sunday, 14 August 2022 03:43 GMT

New Anti-Tumor Hydrogel May Help In Fight Against Cancer, Chinese Study Reveals


(MENAFN- Emirates News Agency (WAM))

BEIJING, 4th August, 2022 (WAM) -- Chinese scientists have designed a hydrogel that may have a double effect in the fight against cancer, as it helps burn up tumors more accurately and boost one's anti-tumor immunity.

According to Chinese news agency, Xinhua, the study, published on Thursday in the journal Science Advances, described the metal-based biomaterial that is shown to enhance the heating efficiency and restrict the heating zone under microwave exposure, a local tumor ablation strategy used clinically.

Scientists from the Institute of Functional Nano & Soft Materials at Soochow University enveloped calcium and manganese ions into a tiny alginate-based hydrogel that can produce more heat in a restricted, targeted spot and avoid causing thermal damage to nearby healthy tissues.

Also, the existence of excess extracellular calcium ions is shown to sensitise cancer cells to mild thermal damage, thus promoting complete ablation of the primary tumor, according to the study.

Then, those cancer cells burnt to death will further work together with calcium and manganese ions to prime effective innate and adaptive anti-tumor immune responses.

The molecular pathways activated in this mechanism can suppress the growth of both metastatic and relapsed tumors, said the paper's co-corresponding authors Feng Liangzhu and Liu Zhuang with Soochow University.

The researchers are now exploring the possibilities of clinical translation, said Feng.

WAM/Amjad Saleh

MENAFN04082022000061011009ID1104648561


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.